Omada Health Financial Ratios
NASDAQ: OMDAHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Omada Health ratio analysis
Omada Health earned a net margin of -4.9% in FY 2025, up from -27.8% a year earlier. Gross margin was 65.7% compared with a median of 58.8% over the prior 2 years. Return on equity reached -5.6%, meaning Omada Health generated -0.06 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.00, and the current ratio was 3.60. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Omada Health financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Price / sales | 2.10 | — | — |
| Price / book | 2.38 | — | — |
| Gross margin | 65.7% | 60.6% | 57.0% |
| Operating margin | -4.6% | -25.7% | -53.8% |
| Net margin | -4.9% | -27.8% | -55.0% |
| Free cash flow margin | 6.5% | -20.5% | -40.8% |
| Return on equity (ROE) | -5.6% | — | — |
| Return on assets (ROA) | -4.2% | -31.2% | — |
| Debt / equity | 0.00 | — | — |
| Current ratio | 3.60 | 2.10 | — |
| Revenue growth | 53.2% | 38.3% | — |